Sitagliptin-Metformin-Mepha retard 50/500 mg, Tabletten mit veränderter Wirkstofffreisetzung

7680690330026 CH-69033 Tabletten mit veränderter Wirkstofffreisetzung

Associated product:

SITAGLIPTIN Metform Mepha retard 50/500mg 160 pce
Sitagliptin-Metformin-Mepha retard 50/500 mg, Tabletten mit veränderter Wirkstofffreisetzung
Sitagliptin-Metformin-Mepha retard 50/500 mg, Tabletten mit veränderter Wirkstofffreisetzung
Sitagliptin-Metformin-Mepha retard 50/500 mg, Tabletten mit veränderter Wirkstofffreisetzung
1 / 3
google

Article details

Package size
160
Selling units
160
Measure
Tablette(n)
Galenic form
Tabletten mit veränderter Wirkstofffreisetzung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/03/2024
Patient information leaflet
Français
11/03/2024
Patient information leaflet
Italien
11/03/2024
Summary of Product Characteristics
Allemand
11/03/2024
Summary of Product Characteristics
Français
11/03/2024
Summary of Product Characteristics
Italien
11/03/2024

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
2.147 MG Substance HBESI

Reimbursement information

Public price
CHF 60.25
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/12/2023

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
69033
Drug name
Sitagliptin-Metformin-Mepha retard, Tabletten mit veränderter Wirkstofffreisetzung
Galenic form
TABWF
ATC Code
A10BD07
Authorization status
Z
Dispensing category
B
First authorization
18/04/2023
Authorization expiration date
17/04/2028
IT Number
07.06.2.
Domain
Human medicine
Field of application
Diabetes mellitus Typ 2

Package details

Description (FR)
SITAGLIPTIN Metform Mepha retard 50/500mg 160 pce
Description (DE)
SITAGLIPTIN Metform Mepha retard 50/500mg 160 Stk
Market launch
18/04/2023
Narcotic (BTM)
No

Original drug

Janumet, Filmtabletten
GTIN: 7680584500016
CHF 41.30
View original

Other package sizes (5)

SITAGLIPTIN Metform Mepha retard 50/500mg 60 pce
60 TABL
GTIN: 7680690330019
View
SITAGLIPTIN Metform Mepha retard 50/1000mg 60 pce
60 TABL
GTIN: 7680690330033
View
SITAGLIPTIN Metform Mepha retard 50/1000mg 160 pce
160 TABL
GTIN: 7680690330040
View
SITAGLIPTIN Metform Mepha retard 100/1000mg 30 pce
30 TABL
GTIN: 7680690330057
View
SITAGLIPTIN Metform Mepha retard 100/1000mg 90 pce
90 TABL
GTIN: 7680690330064
View